Kirkland Reps Baxter International In $380M Baxa Buy
Baxter International Inc. announced Thursday that it had reached an agreement to purchase Baxa Corp., which develops oral and intravenous drug delivery systems, for $380 million....To view the full article, register now.
Already a subscriber? Click here to view full article